M. E. Prins

Statistics

Publications

Citations

1.1K

H-Index

Active since

1995

Affiliations

SNV Netherlands Development Organisation(Current)

Copenhagen University Hospital

Herlev Hospital

M. E. Prins is an author at SNV Netherlands Development Organisation specializing in neuromuscular blocking agents, sugammadex reversal, and neuromuscular blockade.

Publications per year

1995–2010

Publications

Reversal of Rocuronium-induced Neuromuscular Block by the Selective Relaxant Binding Agent Sugammadex

Iben Foss Sorgenfrei, K. Norrild, Per Larsen et al. · Anesthesiology · 2006 · 341 citations

Medicine, Pharmacokinetics, Pharmacology +17

Reversal of Profound, High-dose Rocuronium-induced Neuromuscular Blockade by Sugammadex at Two Different Time Points: An International, Multicenter, Randomized, Dose-finding, Safety Assessor-blinded, Phase II Trial

F. Pühringer, Christopher Rex, Andreas W. Sielenkämper et al. · Anesthesiology · 2008 · 238 citations

Medicine, Pharmacology, Pharmacotherapy +14

Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial

Manfred Blobner, Lars I. Eriksson, Jens Scholz et al. · European Journal of Anaesthesiology · 2010 · 237 citations

Medicine, Anesthesiology, Surgery +14

Reversal of Rocuronium-Induced Neuromuscular Block with the Novel Drug Sugammadex Is Equally Effective Under Maintenance Anesthesia with Propofol or Sevoflurane

Bernard Vanacker, Karel M. Vermeyen, Michel Struys et al. · Anesthesia & Analgesia · 2007 · 142 citations

Medicine, Anesthesiology, Pharmacology +16

Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine

E. Flockton, P Mastronardi, J.M. Hunter et al. · British Journal of Anaesthesia · 2008 · 130 citations · Full text

Medicine, Pharmacotherapy, Neuromuscular Disorders +7

1–5 of 7